BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37541820)

  • 1. Multiple Myeloma in Adolescent and Young Adults: An ASCO CancerLinQ and SEER Analysis.
    Gibson S; Thornton J; Sunderland K; Pham K; DeStefano C
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e335-e340. PubMed ID: 37541820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at Primary Malignancy Determines Survival in Adolescent and Young Adults That Develop a Secondary Thyroid Cancer.
    Lau BJ; Goldfarb M
    J Adolesc Young Adult Oncol; 2016 Jun; 5(2):201-8. PubMed ID: 27042962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
    Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States.
    Costa LJ; Brill IK; Brown EE
    Cancer; 2016 Oct; 122(20):3183-3190. PubMed ID: 27548407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.
    Wolfson J; Sun CL; Wyatt L; Stock W; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):312-320. PubMed ID: 28209594
    [No Abstract]   [Full Text] [Related]  

  • 8. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
    Goldfarb M; Rosenberg AS; Li Q; Keegan THM
    Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia.
    Muffly L; Yin J; Jacobson S; Wall A; Quiroz E; Advani AS; Luger SM; Tallman MS; Litzow MR; Foster MC; Erba HP; Appelbaum FR; Larson RA; Keegan THM; Stock W
    Blood Adv; 2022 Jul; 6(14):4085-4092. PubMed ID: 35838753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
    Liu L; Moke DJ; Tsai KY; Hwang A; Freyer DR; Hamilton AS; Zhang J; Cockburn M; Deapen D
    J Natl Cancer Inst; 2019 May; 111(5):509-518. PubMed ID: 30321398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015.
    Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
    JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
    Lalayanni C; Demosthenous C; Iskas M; Kelaidi C; Papathanasiou M; Syrigou A; Athanasiadou A; Papalexandri A; Batsis I; Vardi A; Polychronopoulou S; Sakellari I
    Leuk Lymphoma; 2022 Dec; 63(13):3128-3137. PubMed ID: 36002396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
    Rosenberg AS; Ruthazer R; Paulus JK; Kent DM; Evens AM; Klein AK
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):684-692.e3. PubMed ID: 27771291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
    Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
    JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis.
    Berkman AM; Andersen CR; Cuglievan B; McCall DC; Lupo PJ; Parsons SK; DiNardo CD; Short NJ; Jain N; Kadia TM; Livingston JA; Roth ME
    Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1176-1184. PubMed ID: 35553621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent and young adult cancer survival.
    Lewis DR; Seibel NL; Smith AW; Stedman MR
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):228-35. PubMed ID: 25417236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis.
    Ailawadhi S; Advani P; Yang D; Ghosh R; Swaika A; Roy V; Foran J; Colon-Otero G; Chanan-Khan A
    Cancer; 2016 Feb; 122(4):618-25. PubMed ID: 26565660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.